[1]
“Correlation between Diabetic Control and Visual Outcomes of Aflibercept versus Bevacizumab Therapy in Iraqi Patients with Diabetic Macular Edema”, AJPS, vol. 26, no. 1, pp. 147–161, Mar. 2026, doi: 10.32947/ajps.v26i1.1385.